From the Editor-in-Chief
Altering the gut microbiota and microbiome could become a strategy for cancer prevention and treatment.
by William G. Nelson, MD, PhD
What Is CRISPR? | Longer Treatment May Benefit Some Breast Cancer Patients | Addressing Depression in Adult Cancer Survivors | The Impact of Rising Drug Costs | Report Links Excess Weight to Eight More Cancer Types | Little Consensus on Ovarian Cancer Monitoring | No Link Found Between IVF and Breast Cancer Risk | World Cancer Day: Accelerating Progress
Your Cancer Guide
A cancer diagnosis can prompt survivors to question or deepen their faith.
by Hester Hill Schnipper
Caregiving With Confidence
Take these steps to delegate responsibilities and strike a balance.
by Liz Seegert
A breast cancer survivor recounts how she became a resource for others.
by Cynthia Ryan
Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
Oncologists and researchers are looking for new drug combinations that extend patient survival without worsening side effects, but it's a daunting task.
by Stephen Ornes
A cancer survivor embarks on a spiritual journey to Poland and finds inspiration in a local cancer hospital.
Reaping Grains' Benefits | Put a Cork in It
Cancer survivor Ann Ogden Gaffney left her job in fashion to teach other cancer survivors how to cook.
Coping with a difficult parent, sexual activity during treatment, and talking with children about inheritable cancers.
A diverse donor pool benefits patients in need of bone marrow transplants.
by Lindsey Konkel
Darla Moore, Janiela Roachford, Roseanne Venturino.
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.
by Judy Pearson
Modulation of the tumor microenvironment by aging and obesity could potentially be exploited to treat cancer.
As Joe Biden begins his presidency, the cancer research community is watching to see what steps he takes to promote the search for cancer cures.
Decades of cancer vaccine research enabled the rapid development of COVID-19 vaccines.
Learning Medicare’s ABCDs
donate to the AACR